PD-Rx Pharmaceuticals, Inc. (PDRX)
OTCMKTS · Delayed Price · Currency is USD
2.750
0.00 (0.00%)
At close: Aug 8, 2025
PD-Rx Pharmaceuticals Market Cap
PD-Rx Pharmaceuticals has a market cap or net worth of $4.52 million as of August 26, 2025. Its market cap has decreased by -10.45% in one year.
Market Cap
4.52M
Enterprise Value
-880.50K
Revenue
18.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.75
Market Cap Chart
Since March 1, 1993, PD-Rx Pharmaceuticals's market cap has increased from 1.16M to 4.52M, an increase of 290.32%. That is a compound annual growth rate of 4.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 4.52M | -9.84% |
| Dec 23, 2024 | 5.02M | -56.43% |
| Dec 20, 2023 | 11.51M | 16.65% |
| Dec 30, 2022 | 9.87M | 130.18% |
| Dec 27, 2021 | 4.29M | -9.09% |
| Dec 31, 2020 | 4.72M | -24.66% |
| Dec 18, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 634.05M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.36M |
| Northwest Biotherapeutics | 366.64M |